PLC β 4 Antibodies

Santa Cruz Biotechnology delivers a wide array of PLC β 4 monoclonal antibodies for investigating phospholipase C beta 4 in cellular signaling pathways. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipase C beta 4 catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate, generating inositol trisphosphate and diacylglycerol, which are essential for intracellular signaling. PLC β 4 influences numerous physiological processes, including neurotransmitter release and cell proliferation. Research into PLC β 4 continues to reveal its significance in neurological disorders and various pathologies. Investigating PLC β 4 helps scientists understand cellular communication mechanisms and signal transduction pathways. Detailed characterization of PLC β 4 provides valuable information about its role in health and disease. Understanding PLC β 4 regulation advances knowledge of cellular responses to external stimuli. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of phospholipase C beta 4 and its impact on human health.